Concepedia
Statistics
Publications
20
Citations
1.5K
H-Index
16
Active since
1975
Affiliations
AstraZeneca (United Kingdom)(Current)
Pfizer (United States)
GlaxoSmithKline (United States)
Sanofi (United States)
Bristol-Myers Squibb (United States)
Graham R. Betton is an author at AstraZeneca (United Kingdom) specializing in medicine, urology, and pharmacology.
Top concepts
MedicineUrologyPharmacologyToxicologyPathologyNephrologyHistopathologyRenal PathologyVeterinary ScienceAcute Kidney Injury
Publications per year
1975–2012
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 403 citations
Translational Medicine, Urology, Renal Function +9
Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System
Kendall S. Frazier, John Curtis Seely, Gordon C. Hard et al. · Toxicologic Pathology · 2012 · 288 citations
International Harmonization, Pathology, Experimental Pathology +16
Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat
Ernie Harpur, Daniela Ennulat, David Hoffman et al. · Toxicological Sciences · 2011 · 121 citations · Full text
Renal Pathology, Renal Inflammation, Pathology +29
Towards consensus practices to qualify safety biomarkers for use in early drug development
Frank D. Sistare, Frank Dieterle, Sean P. Troth et al. · Nature Biotechnology · 2010 · 120 citations
Drug Safety, Predictive Toxicology, Preclinical Drug Evaluation +10
Gastric ECL-Cell Hyperplasia and Carcinoids in Rodents Following Chronic Administration of H<sub>2</sub>-Antagonists SK&F 93479 and Oxmetidine and Omeprazole
Graham R. Betton, Charles S. Dormer, T.C.E. Wells et al. · Toxicologic Pathology · 1988 · 115 citations · Full text
1–5 of 20